Latest Innovation News

RocketDNA Ltd reported a slight revenue decline and increased losses in H1 2025 but marked significant progress in drone technology deployments and operational certifications.

Sprintex Limited reported a 26% revenue increase for FY25 but also a 37% rise in net loss, as it accelerates global expansion through key distribution deals and manufacturing upgrades.

Alcidion Group Limited has delivered a record FY25 with $40.8 million in revenue and underlying EBITDA of $5.1 million, driven by a landmark $39 million UK electronic patient record contract and strong recurring revenue growth.

Summerset Group Holdings Limited reported a robust first half in 2025, with underlying profit up 19% and record sales driving momentum across New Zealand and Australia.

BirdDog Technology Limited has requested suspension of its shares from ASX trading as it prepares to exit the official exchange list, marking a significant shift for the broadcasting technology firm.

Macquarie Technology Group Limited reported solid FY25 results with continued EBITDA growth and strong cash conversion, underpinned by strategic investments in data centre capacity and AI capabilities.

Macquarie Technology Group has reported its eleventh consecutive year of EBITDA growth, driven by strategic investments in data centre infrastructure and AI capabilities. The company is advancing its IC3 SuperWest project and has secured land for a new Sydney data centre campus.

Shriro Holdings reported a 5.5% beat on EBITDA guidance despite a 13.6% revenue decline driven by strategic shifts in its importer model and distributor consolidation. The company signals optimism for FY26 with new product launches and a capital-light growth strategy.

Shriro Holdings reported a 5.5% rise in EBITDA for FY25 despite a 13.6% revenue dip, driven by strategic shifts including a new US distributor and innovative BBQ product launches.

Cyclopharm Limited reported a 26% revenue increase for the half year ended June 2025, driven by rapid US market expansion and strong growth in its Third-Party distribution business. Despite a wider net loss, the company secured a key patent extension and reaffirmed its target to install 250-300 Technegas® systems in the US by late 2026.

BPH Energy Limited reported a 49% increase in net profit for FY2025, driven by gains in its energy and biotech investments, while facing a pivotal Federal Court hearing over the renewal of the PEP-11 offshore gas exploration permit.

Nova Eye Medical has delivered solid FY25 results, meeting sales guidance outside China and achieving six consecutive halves of growth in the US market. The company also improved gross margins and reduced cash burn, setting an optimistic tone for FY26 with breakeven EBITDA guidance.